AR038622A1 - SALTS OF THE CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS - Google Patents

SALTS OF THE CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS

Info

Publication number
AR038622A1
AR038622A1 ARP030100660A ARP030100660A AR038622A1 AR 038622 A1 AR038622 A1 AR 038622A1 AR P030100660 A ARP030100660 A AR P030100660A AR P030100660 A ARP030100660 A AR P030100660A AR 038622 A1 AR038622 A1 AR 038622A1
Authority
AR
Argentina
Prior art keywords
medications
procedures
salts
preparation
cinamic acid
Prior art date
Application number
ARP030100660A
Other languages
Spanish (es)
Inventor
Linz Guenter Dr
Soyka Rainer Dr
Original Assignee
Ingelheim Am Rhein Alemania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002109243 external-priority patent/DE10209243A1/en
Priority claimed from DE2002116124 external-priority patent/DE10216124A1/en
Application filed by Ingelheim Am Rhein Alemania filed Critical Ingelheim Am Rhein Alemania
Publication of AR038622A1 publication Critical patent/AR038622A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Reivindicación 1: Compuestos de la fórmula general (1) en donde: R1 y R2, iguales o diferentes, significan hidrógeno, alquilo C1-4, alcoxi C1-4, halógeno, -CF3 ó fenilo, ó si R1 y R2 están contiguos, significan juntos un puente de -CH=CH-CH=CH-; R3 significa hidrógeno, alquilo C1-4, alcoxi C1-4, halógeno ó -CF3; eventualmente en forma de sus enantiómeros, mezclas de los enantiómeros o racematos.Claim 1: Compounds of the general formula (1) wherein: R1 and R2, the same or different, mean hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen, -CF3 or phenyl, or if R1 and R2 are contiguous, together they mean a bridge of -CH = CH-CH = CH-; R3 means hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen or -CF3; possibly in the form of their enantiomers, mixtures of the enantiomers or racemates.

ARP030100660A 2002-03-04 2003-02-28 SALTS OF THE CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS AR038622A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002109243 DE10209243A1 (en) 2002-03-04 2002-03-04 Synergistic, well tolerated medicament combination of tiotropium salt and sparingly water-soluble salmeterol salt, useful for treating asthma or chronic obstructive pulmonary disease
DE2002116124 DE10216124A1 (en) 2002-04-12 2002-04-12 New cinnamic acid salts of salmeterol useful for the treatment of e.g. chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
AR038622A1 true AR038622A1 (en) 2005-01-19

Family

ID=27789722

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100660A AR038622A1 (en) 2002-03-04 2003-02-28 SALTS OF THE CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS

Country Status (9)

Country Link
EP (1) EP1483231A1 (en)
JP (1) JP2005519110A (en)
AR (1) AR038622A1 (en)
AU (1) AU2003221482A1 (en)
CA (1) CA2477714C (en)
PE (1) PE20030933A1 (en)
TW (1) TW200404759A (en)
UY (1) UY27686A1 (en)
WO (1) WO2003074469A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2265276B1 (en) * 2005-05-20 2008-02-01 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310477D0 (en) * 1983-04-18 1983-05-25 Glaxo Group Ltd Chemical compounds
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4791108A (en) * 1987-04-13 1988-12-13 Syntex (U.S.A.) Inc. Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Pharmaceutical compositions comprising salmeterol and fluticasone propionate
RU2081108C1 (en) * 1991-10-16 1997-06-10 Циба-Гейги АГ Additive salts of acids with the base and pharmaceutical composition showing antitumor activity

Also Published As

Publication number Publication date
JP2005519110A (en) 2005-06-30
CA2477714A1 (en) 2003-09-12
TW200404759A (en) 2004-04-01
WO2003074469A1 (en) 2003-09-12
UY27686A1 (en) 2003-10-31
PE20030933A1 (en) 2003-12-15
CA2477714C (en) 2011-01-25
AU2003221482A1 (en) 2003-09-16
EP1483231A1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
AR051485A1 (en) PIRAZOLO PIRIMIDINAS 1,4-REPLACED AS QUINASE INHIBITORS
UY30498A1 (en) NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
AR068479A1 (en) (CARBOXILALQUILENFENIL) PHENYLOXAMIDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COOMPOSITION
CO6220855A2 (en) BASED COMPOSITE OF 54-PHENYL-6- (2,2,2-TRIFLUORO-1-PHENYLETOXI) PYRIMIDINE AND METHODS FOR USE
CR7865A (en) DERIVATIVES OF DIHYDROPIRANOINDOL -3,4-DIONA SUBSTITUTED AND DERIVATIVES OF 2-HYDROXIMETHYLINDOL OF THE 3-OXOACETIC ACID REPLACED AS INHIBITORS OF THE PLASMINOGEN 1 ACTIVATOR INHIBITOR (PAI-1)
ES2314418T3 (en) DERIVATIVES OF AMIDAS OF THE ACID 4-BROMO-5- (2-CHLOROBENZOYLAMINE) -1H-PIRAZOL-3-CARBOXYCLIC AND RELATED COMPOUNDS AS ANTIGONISTS OF THE B1 BRADIQUININE RECEPTOR FOR THE TREATMENT OF INFLAMMATORY DISEASES.
AR052866A1 (en) SUBSTITUTED MONOCICLIC PHENYL-METANONES
RS53627B1 (en) N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
ECSP056041A (en) PIRAZOLOPIRIDINE DERIVATIVES
AR039868A1 (en) SELECTIVE INHIBITORS OF THE PLASMATIC KALIKREINA ENZYME
UY28572A1 (en) NEW COMPOUNDS
GT200500175A (en) CETP INHIBITORS
UY28514A1 (en) NEW COMPOUNDS
RS52978B (en) Fused amino pyridine as hsp90 inhibitors
ECSP10010415A (en) NEW COMPOUNDS THAT ARE ERK INHIBITORS
CO6260061A2 (en) (CICLOPROPILFENIL) PHENYLOXAMIDS METHOD FOR PRODUCTION AND USE AS A MEDICINAL PRODUCT
UY28342A1 (en) NEW COMPOUNDS
CR9602A (en) NEW DERIVATIVES OF 2,4-DIANILINPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND PARTICULARLY AS IKK INHIBITORS
UY3485Q (en) PERFUME PACK (B9)
CR11518A (en) CARBAMOIL COMPOUNDS AS DGAT1 190 INHIBITORS
AR058077A1 (en) DERIVATIVES OF PHENOXYACETIC ACIDS
AR053149A1 (en) USE OF DIOSMETINE COMPOUNDS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE PREVENTION AND / OR TREATMENT OF THROMBOTIC PATHOLOGIES AND PATHOLOGIES THAT CONCLUDE THE RISK OF PRODUCING THROMBOSIS
AR063988A1 (en) HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR049995A1 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES N-PIPERIDINO-1,5-DIFENILPIRAZOL-3-CARBOXAMIDA
CR10206A (en) ACIDS 4-PHENYL-TIAZOL-5-CARBOXYLIC AMIDES OF ACIDS 4-PHENYL-TIAZOL-5-CARBOXYLICS AS INHIBITORS OF THE PLK1

Legal Events

Date Code Title Description
FA Abandonment or withdrawal